Reuters Photo Credit: Reuters

SEBI fines Piramal over violation of insider trading norms during Abbott deal

By PTI
04 October, 2016

Sebi today imposed Rs 6 lakh fine on five entities including Piramal Enterprises, its chairman Ajay Piramal as well as his wife Swati and daughter Nandini for lapses on insider trading control in connection with the sale of domestic healthcare business to Abbott.

The penalty has also been imposed on N Santhanam.

The Securities and Exchange Board of India (Sebi) has disposed of charges against the company’s director Harinder Sikka saying he cannot be faulted for the transactions as the company had not closed the trading window which would have checked his trades by way of grant of pre-clearances.

The markets regulator found that entities failed to handle the ‘Unpublished Price Sensitive Information’ relating to the sale of domestic healthcare formulation business by to Abbott on a ‘need to know’ basis as Anand Piramal who is neither employee nor Director was privy to the decision at every stage and therefore violated the regulations.

Also, they failed to implement the model code of conduct by not announcing closure of trading window on account of the information pertaining to sale of domestic business to Abbott.

Besides, they did not place the material information with respect to the transaction before the Board of Piramal Enterprises during the process of decision.

Accordingly, it has imposed the fine on the five entities for violating provision related to Prohibition of Insider Trading (PIT) Regulations. The five entities “shall be liable jointly and severally” to pay the penalties.

In a late evening statement, Piramal Enterprises said it would evaluate the options after receiving the Sebi order.

“This issue pertains to a procedural provision with no gains to the promoter family or the management. Once we receive the order from Sebi, we will evaluate our options,” the statement said.

Like this report? Sign up for our daily newsletter to get our top reports.


Leave Your Comment
Piramal Sells Diagnostic Biz To Super Religare For Rs 600Cr

Piramal Sells Diagnostic Biz To Super Religare For Rs 600Cr

Reghu Balakrishnan 1 year ago
This is the second major business that Ajay Piramal-owned Piramal Healthcare has divested in recent months. Piramal Healthcare Limited has announced that Super Religare Laboratories...
Piramal Healthcare Completes Sale Of Domestic Formulations Biz

Piramal Healthcare Completes Sale Of Domestic Formulations Biz

TEAM VCC 7 years ago
Piramal Healthcare Limited today said that it has completed the sale of its domestic formulations business to Abbott Labs. Piramal Healthcare Limited had entered into...
Abbott To Acquire Piramal Healthcare Unit For $3.72B

Abbott To Acquire Piramal Healthcare Unit For $3.72B

Reghu Balakrishnan 7 years ago
Indian pharma firms continue to be attractive cross-border M&A targets. NYSE-listed pharma major Abbott Labs has inked a deal with Piramal Healthcare to acquire Piramal’s...
No Comments

SEBI fines Piramal over violation of insider trading norms during Abbott deal

Powered by WordPress.com VIP